IBIO Stock Catalyst: iBio Announces Progress in Obesity Drug Development

Dec 9, 2025 · 6:59pm ET

Company's stock price rises on positive news.

Max move

+72.8%

High of day $3.82

Sparker timei

6:59pm ET

IBIO · Dec 9, 2025

CATALYST DATE · 1-MINUTE BARS

Catalyst Summary

iBio, Inc. (Nasdaq: IBIO) reported on December 9, 2025, that its stock price increased due to significant momentum in the development of its obesity drug. The announcement highlighted the company's advancements in this critical area of healthcare.

The progress in the obesity drug development has generated positive market sentiment, contributing to the rise in iBio's stock price. The company's free float stands at 21,441,000 shares.

This summary was generated by AI from public sources and may contain errors. Not financial advice. Trade at your own risk.

Real-time alerts

Get notified the next time IBIO sparks.

Download Sniper App →

Catch the next IBIO-style move in real time.

Day Trader Sniper alerts you the moment a setup like this triggers: premarket, open, or intraday.

Watch demo Download Free →